Knowledge Hub

Market Report Focus On Teva Pharmaceutical Industries Ltd (TEVA) - Product Pipeline Analysis, 2016

Press Release   •   Feb 08, 2017 05:32 EST

Teva Pharmaceutical Industries Ltd (Teva) is a pharmaceutical company that carries out the research, development, manufacture and commercialization of generics, branded pharmaceuticals and active pharmaceutical ingredients (APIs). It offers chemical and generic medicines in various forms such as capsules, tablets, ointments, liquids, creams, injectables and inhalants. The company offers specialty pharmaceuticals in central nervous system, respiratory, cancer and womens health. Teva also provides over-the-counter (OTC) products through a joint venture with P&G in Israel and Hungary. It has operations in United States, Europe and Rest of the World (Japan, Canada, Venezuela and Russia). Teva is headquartered in Tikva, Israel.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

View Report at:


- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Teva Pharmaceutical Industries Ltd

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Download Sample copy of this Report at:

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Teva Pharmaceutical Industries Ltd Company Overview 6

Teva Pharmaceutical Industries Ltd Company Snapshot 6

Teva Pharmaceutical Industries Ltd Pipeline Products and Clinical Trials Overview 6

Teva Pharmaceutical Industries Ltd Pipeline Analysis Overview 9

Business Description 9

Key Facts 10

Teva Pharmaceutical Industries Ltd - Major Products and Services 11

Teva Pharmaceutical Industries Ltd Pipeline Products by Development Stage 13

Teva Pharmaceutical Industries Ltd Clinical Trials by Trial Status 15

Teva Pharmaceutical Industries Ltd Pipeline Products Overview 17


BYETTA Product Overview 17

Diagnostic Assay - Ovarian Cancer 18

Diagnostic Assay - Ovarian Cancer Product Overview 18

Drug Delivery Patch 19

Drug Delivery Patch Product Overview 19

Epinephrine Pre-Filled Syringe 20

Epinephrine Pre-Filled Syringe Product Overview 20

Injectable Device 21

Injectable Device Product Overview 21

MicroDose Needlefree System 22

MicroDose Needlefree System Product Overview 22

New Inhaler Device Platform 23

New Inhaler Device Platform Product Overview 23

NP201 24

NP201 Product Overview 24

NP202 25

NP202 Product Overview 25

QVAR Breath-Actuated Inhaler (BAI) 26

QVAR Breath-Actuated Inhaler (BAI) Product Overview 26

Spiromax EU / mDPI US 27

Spiromax EU / mDPI US Product Overview 27

Spiromax EU / mDPI US Clinical Trial 28

Tidal Inhaler 29

Tidal Inhaler Product Overview 29

Wearable Device - Huntington Disease 30

Wearable Device - Huntington Disease Product Overview 30

Teva Pharmaceutical Industries Ltd - Key Competitors 31

Teva Pharmaceutical Industries Ltd - Key Employees 32

Teva Pharmaceutical Industries Ltd - Key Employee Biographies 34

Teva Pharmaceutical Industries Ltd - Locations And Subsidiaries 35

Head Office 35

Other Locations & Subsidiaries 35

Recent Developments 45

Teva Pharmaceutical Industries Ltd, Recent Developments 45

Dec 22, 2016: Teva Pharmaceutical Paying $519 Million to Settle FCPA Charges 45

Dec 22, 2016: Teva Reaches Settlement with Government on FCPA 45 is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.